PCV

PRODUCT
COMPANY
INSIGHTS
CONTACT

PCV

PRODUCT
COMPANY
INSIGHTS
CONTACT

your hub for the next generation of heart health

Explore the latest updates, research, and innovations shaping the future of heart failure prevention and management

PCV Appoints Matthew I. Mace to Board of Directors

Company
•
February 10, 2025

PCV Appoints Matthew I. Mace to Board of Directors

Company
•
February 10, 2025

PCV Appoints Matthew I. Mace to Board of Directors

Company
•
February 10, 2025
Industry
•
February 9, 2025

Hospital at Home: A New Frontier in Post-Acute Care

Industry
•
February 9, 2025

Hospital at Home: A New Frontier in Post-Acute Care

Industry
•
February 9, 2025

Hospital at Home: A New Frontier in Post-Acute Care

Innovations
•
February 9, 2025

Remote Patient Monitoring: A New Era in Chronic Care

Innovations
•
February 9, 2025

Remote Patient Monitoring: A New Era in Chronic Care

Innovations
•
February 9, 2025

Remote Patient Monitoring: A New Era in Chronic Care

Innovations
•
February 9, 2025

Stress and Cardiac Health: An Opportunity in Modern Care

Innovations
•
February 9, 2025

Stress and Cardiac Health: An Opportunity in Modern Care

Innovations
•
February 9, 2025

Stress and Cardiac Health: An Opportunity in Modern Care

Industry
•
February 9, 2025

Digital Health: Breaking Down Data Silos

Industry
•
February 9, 2025

Digital Health: Breaking Down Data Silos

Industry
•
February 9, 2025

Digital Health: Breaking Down Data Silos

PRECISION CARDIOVASCULAR

precision
cardiovascular

Privacy Policy

PCV PULSENSE® is an investigational device and is not yet approved for commercial sale. It is currently undergoing regulatory review and clinical evaluation to ensure safety and efficacy. The device is limited by federal law to investigational use only and has not been cleared or approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the U.S. Food and Drug Administration (FDA), or the European Medicines Agency (EMA).

PCV PULSENSE® is an investigational device and is not yet approved for commercial sale. It is currently undergoing regulatory review and clinical evaluation to ensure safety and efficacy. The device is limited by federal law to investigational use only and has not been cleared or approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the U.S. Food and Drug Administration (FDA), or the European Medicines Agency (EMA).

© 2025 Precision Cardiovascular Ltd — All rights reserved
© 2025 Precision Cardiovascular Ltd — All rights reserved
© 2025 Precision Cardiovascular Ltd — All rights reserved

Company registered in England & Wales, No. 13366126 | The Magdi Yacoub Institute, Harefield Hospital, Harefield, Uxbridge UB9 6JH

Company registered in England & Wales, No. 13366126 | The Magdi Yacoub Institute, Harefield Hospital, Harefield, Uxbridge UB9 6JH

Company registered in England & Wales, No. 13366126 | The Magdi Yacoub Institute, Harefield Hospital, Harefield, Uxbridge UB9 6JH

PCV

PCV